1.
Sturm A, Sun P, Avila-Pacheco J, et al. Genetic factors affecting storage and utilization of lipids during dormancy in . mBio. 2024:e0320823. doi:10.1128/mbio.03208-23.
1.
Fang C, Lee KK, Nietupski R, et al. Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors. Bioorg Med Chem Lett. 2018;28(22):3529-3533. doi:10.1016/j.bmcl.2018.09.037.
1.
Fernando DM, Gee CT, Griffith EC, et al. Biophysical analysis of the Mycobacteria tuberculosis peptide binding protein DppA reveals a stringent peptide binding pocket. Tuberculosis (Edinb). 2022;132:102157. doi:10.1016/j.tube.2021.102157.
1.
Libardo DJ, de la Fuente-Núñez C, Anand K, et al. Phagosomal Copper-Promoted Oxidative Attack on Intracellular Mycobacterium tuberculosis. ACS Infect Dis. 2018;4(11):1623-1634. doi:10.1021/acsinfecdis.8b00171.
1.
Wellington S, Nag PP, Michalska K, et al. A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. Nat Chem Biol. 2017;13(9):943-950. doi:10.1038/nchembio.2420.
1.
Kurthkoti K, Amin H, Marakalala MJ, et al. The Capacity of To Survive Iron Starvation Might Enable It To Persist in Iron-Deprived Microenvironments of Human Granulomas. MBio. 2017;8(4). doi:10.1128/mBio.01092-17.
1.
Georgescu CH, Manson AL, Griggs AD, et al. SynerClust: a highly scalable, synteny-aware orthologue clustering tool. Microb Genom. 2018;4(11). doi:10.1099/mgen.0.000231.
1.
Zhang W, Lun S, Wang S-H, et al. Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. J Med Chem. 2018;61(3):791-803. doi:10.1021/acs.jmedchem.7b01319.
1.
Warner DF, Rock JM, Fortune SM, Mizrahi V. DNA Replication Fidelity in the Mycobacterium tuberculosis Complex. Adv Exp Med Biol. 2017;1019:247-262. doi:10.1007/978-3-319-64371-7_13.
1.
Wellington S, Hung DT. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets. ACS Infect Dis. 2018;4(5):696-714. doi:10.1021/acsinfecdis.7b00255.